Cargando…
A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer()()
AIM: SMAD4 immunohistochemistry is considered a valuable prognostic marker in colorectal cancer, but individual studies have often been small and the results variable. A meta-analysis could potentially clarify these findings. METHODS: In September 2014, a Pubmed and Google Scholar search was conduct...
Autores principales: | Voorneveld, Philip W., Jacobs, Rutger J., Kodach, Liudmila L., Hardwick, James C.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350636/ https://www.ncbi.nlm.nih.gov/pubmed/25749173 http://dx.doi.org/10.1016/j.tranon.2014.11.003 |
Ejemplares similares
-
Meta-Analysis of the Prognostic Value of Smad4 Immunohistochemistry in Various Cancers
por: Du, Yiping, et al.
Publicado: (2014) -
The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer
por: Kodach, Liudmila L., et al.
Publicado: (2010) -
The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers
por: Ong, Chee Wee, et al.
Publicado: (2015) -
The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC
por: Voorneveld, P W, et al.
Publicado: (2015) -
Assessment of beta-catenin expression by immunohistochemistry in colorectal neoplasms and its role as an additional prognostic marker in colorectal adenocarcinoma
por: Bhattacharya, Indroneel, et al.
Publicado: (2019)